ACTA1 and Hepatic fibrosis: According to the present study findings, RF can reduce liver fibrosis by altering TGF-β/Smad signaling by decreasing protein expression of Smad2/3 phosphorylation and Smad4 formation, which results in down-regulation of Col1A1 and α-SMA transcriptions.